Innovative Product Portfolio Logos Biosystems has developed a broad range of automated cell counters and imaging instruments, such as the LUNA series and OnCellCounter, positioning it well to meet diverse laboratory needs in cellular and molecular research, creating opportunities for upselling or expanding product adoption.
Recent Technology Launches The company's recent launches of advanced instruments like the LUNA-III and the OnCellCounter demonstrate its commitment to innovation, enabling sales teams to emphasize cutting-edge solutions that keep labs competitive and enhance research efficiency.
Recognition and Credibility Winning awards such as the 2023 Reviewers’ Choice Life Science Company of the Year boosts Logos Biosystems' credibility, making it easier to engage research institutions seeking reputable and trusted suppliers of high-quality life science tools.
Market Penetration Strategy With collaborations and published educational content like the Biocompare article and partnerships with science publishers, there are opportunities to leverage thought leadership to attract new customers looking for expertise in automated cell counting and nuclei isolation.
Growing Revenue Potential Operating within the biotechnology research industry with revenue estimated between $25M and $50M and continuous product innovation, Logos Biosystems presents a promising target for expansion into labs invested in automation and digital solutions for cellular analysis.
$1B$10B
$50M$100M
$1B$10B
$250M$500M
$10B
$10B
$10B
$1B$10B
$100M$250M
$250M$500MLogos Biosystems uses 8 technology products and services including Twemoji, Google Fonts API, Moment.js, and more. Explore Logos Biosystems's tech stack below.
| Logos Biosystems Email Formats | Percentage |
| First@logosbio.com | 39% |
| First.Last@logosbio.com | 17% |
| First.Middle@logosbio.com | 5% |
| First@logosbio.com | 39% |
Biotechnology ResearchGyeonggi-do, South Korea11-50 Employees
Logos Biosystems is the life science solutions of Aligned Genetics, Inc., dedicated to the development and commercialization of innovative technologies to support the life science research community. Since its founding in 2008, Logos Biosystems has been developing a series of automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis.
Company Overview
Funding & FinancialsLogos Biosystems's revenue is estimated to be in the range of $25M$50M
Funding & FinancialsLogos Biosystems's revenue is estimated to be in the range of $25M$50M
1-888-653-2347 
support@leadiq.com